Literature DB >> 8694855

Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.

H Yamazaki1, M Nakano, E M Gillam, L C Bell, F P Guengerich, T Shimada.   

Abstract

NADH-dependent 7-ethoxycoumarin O-deethylation activities could be reconstituted in systems containing cytochrome b5 (b5), NADH-b5 reductase, and bacterial recombinant P450 2E1 in 100 mM potassium phosphate buffer (pH 7.4) containing a synthetic phospholipid mixture and cholate. Replacement of NADH-b5 reductase with NADPH-P450 reductase yielded a 4-fold increase in 7-ethoxycoumarin O-deethylation activity, and further stimulation (approximately 1.5-fold) could be obtained when NADPH was used as an electron donor. Removal of b5 from the NADH- and NADPH-supported systems caused a 90% loss of 7-ethoxycoumarin O-deethylation activities in the presence of NADPH-P450 reductase, but resulted in complete loss of the activities in the absence of NADPH-P450 reductase. Km values were increased and Vmax values were decreased for 7-ethoxycoumarin O-deethylation when b5 was omitted from the NADPH-supported P450 2E1-reconstituted systems. Requirements for b5 in P450 2E1 systems were also observed in chlorzoxazone 6-hydroxylation, aniline p-hydroxylation, and N-nitrosodimethylamine N-demethylation. In human liver microsomes, NADH-dependent 7-ethoxycoumarin O-deethylation, chlorzoxazone 6-hydroxylation, aniline p-hydroxylation, and N-nitrosodimethylamine N-demethylation activities were found to be about 55, 41, 33, and 50%, respectively, of those catalyzed by NADPH-supported systems. Anti-rat NADPH-P450 reductase immunoglobulin G inhibited 7-ethoxycoumarin O-deethylation activity catalyzed by human liver microsomes more strongly in NADPH- than NADH-supported reactions, while anti-human b5 immunoglobulin G inhibited microsomal activities in both NADH- and NADPH-supported systems to similar extents. These results suggest that b5 is an essential component in P450 2E1-catalyzed oxidations of several substrates used, that about 10% of the activities occur via P450 2E1 reduction by NADPH-P450 reductase in the absence of b5, and that the NADH-supported system contributes, in part, to some reactions catalyzed by P450 2E1 in human liver microsomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694855     DOI: 10.1016/0006-2952(96)00208-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

1.  Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses.

Authors:  Nicolas Hohmann; Antje Blank; Jürgen Burhenne; Yosuke Suzuki; Gerd Mikus; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2019-08-09       Impact factor: 4.335

2.  Global analysis of protein-protein interactions reveals multiple CYP2E1-reductase complexes.

Authors:  Arvind P Jamakhandi; Petr Kuzmic; Daniel E Sanders; Grover P Miller
Journal:  Biochemistry       Date:  2007-08-09       Impact factor: 3.162

3.  Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes.

Authors:  Aaron G Bart; Emily E Scott
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

4.  P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.

Authors:  Venkataramanan Subramanian; Harshavardhan Doddapaneni; Khajamohiddin Syed; Jagjit S Yadav
Journal:  Curr Microbiol       Date:  2010-03-11       Impact factor: 2.188

5.  Cytochrome P450 7A1 cholesterol 7alpha-hydroxylation: individual reaction steps in the catalytic cycle and rate-limiting ferric iron reduction.

Authors:  Raku Shinkyo; F Peter Guengerich
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

6.  Cross-linking mass spectrometry and mutagenesis confirm the functional importance of surface interactions between CYP3A4 and holo/apo cytochrome b(5).

Authors:  Chunsheng Zhao; Qiuxia Gao; Arthur G Roberts; Scott A Shaffer; Catalin E Doneanu; Song Xue; David R Goodlett; Sidney D Nelson; William M Atkins
Journal:  Biochemistry       Date:  2012-11-14       Impact factor: 3.162

Review 7.  The functional effects of physical interactions involving cytochromes P450: putative mechanisms of action and the extent of these effects in biological membranes.

Authors:  James R Reed; Wayne L Backes
Journal:  Drug Metab Rev       Date:  2016-08       Impact factor: 4.518

8.  P450 reductase and cytochrome b5 interactions with cytochrome P450: effects on house fly CYP6A1 catalysis.

Authors:  Marat B Murataliev; Victor M Guzov; F Ann Walker; René Feyereisen
Journal:  Insect Biochem Mol Biol       Date:  2008-09-27       Impact factor: 4.714

9.  CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.

Authors:  Charles W Locuson; Larry C Wienkers; Jeffrey P Jones; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2007-04-19       Impact factor: 3.922

Review 10.  Cytochrome P450 2E1 and its roles in disease.

Authors:  F Peter Guengerich
Journal:  Chem Biol Interact       Date:  2020-03-18       Impact factor: 5.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.